An ongoing dialogue on HIV/AIDS, infectious diseases,
December 10th, 2008
Unintended Consequences of ART “Rollout”
According to this BBC article, teenagers in South Africa are grinding up antiretrovirals and then smoking them for their “hallucinogenic and relaxing effect”.
(Apologies for the pun on the title.)
It’s impossible to tell with a report like this how widespread the practice is, but it’s potentially worrisome. And no mention in the article which antivirals are being used, though of course one suspects efavirenz. I’ve heard rumors of a “street value” for efavirenz as a mind-altering drug, but not specifically of anyone smoking it.
Does anyone have more details on this?
(Thanks to H Heller for the link.)
Categories: Health Care, HIV, Infectious Diseases, Misc, Patient Care, Policy
Tags: antiretrovirals, clinical care, HIV, Infectious Diseases, Policy
You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.
Comments are closed.
Paul E. Sax, MD
NEJM Journal Watch
Biography | Disclosures | Summaries
Learn more about HIV and ID Observations.
Follow HIV and ID Observations Posts via Email
- Really Rapid Review — CROI 2023, Seattle
- Oral Antibiotic Therapy for Endocarditis — Are We There Yet?
- Three Effective Treatments for COVID-19 Not in Treatment Guidelines — at Least Not Yet
- Learning the Names of HIV Drugs Is Horribly Difficult — Here’s Why
- Medical Masks vs. N95 Respirators for Preventing COVID-19 Among Healthcare Workers
- ID Cartoon Caption Contest (125)
- ID Cartoon Caption Contest #2 Winner — and a New Contest for the Holidays (92)
- Dear Nation — A Series of Apologies on COVID-19 (80)
- How to Induce Rage in a Doctor (77)
- IDSA’s COVID-19 Treatment Guidelines Highlight Difficulty of “Don’t Just Do Something, Stand There” (74)
NEJM Journal Watch — Recent Infectious Disease Articles
- Ceftriaxone for Treatment of Methicillin-Susceptible Staphylococcus aureus Bacteremia?
- Observations from ID and Beyond: Three Effective Treatments for COVID-19 Not in Treatment Guidelines — At Least Not Yet
- Preventive Treatment of Malaria During Pregnancy: The Optimal Strategy Remains Unclear
- Pulmonary Sequelae After COVID-19
- Worldwide Study of Cryptococcal Meningitis in Persons with HIV
- 3tc Abacavir AIDS antibiotics antiretroviral therapy ART atazanavir baseball CDC C diff COVID-19 CROI darunavir dolutegravir elvitegravir etravirine FDA HCV hepatitis C HIV HIV cure HIV testing ID fellowship ID Learning Unit Infectious Diseases influenza Link-o-Rama lyme disease MRSA PEP Policy PrEP prevention primary care raltegravir Really Rapid Review resistance Retrovirus Conference rilpivirine sofosbuvir TDF/FTC tenofovir Thanksgiving vaccines zoster